ABBV - AbbVie - Cerevel deal reportedly followed unusual options trading
2023-12-08 08:01:47 ET
More on AbbVie, Cerevel, etc.
- Cerevel Stock Soars Ahead Of Parkinson's Drug Update - I'm On Sidelines
- AbbVie: 4 Hidden Keys Investors Must Know To Judge ImmunoGen Acquisition
- AbbVie: Risky Purchase Of ImmunoGen Could Pay Off Big Time
- AbbVie shares set for seventh straight session of gains
- Biggest stock movers today: Google, AMD, GameStop, C3.AI, Chewy and more
For further details see:
AbbVie – Cerevel deal reportedly followed unusual options trading